Stanford Launches Data-Driven Model Evaluating COVID-19 Interventions

HealthITAnalytics | April 01, 2020

Researchers at Stanford University have launched an interactive, data-driven model that evaluates possible outcomes of non-pharmaceutical interventions for COVID-19, including social distancing and quarantine. The team aims to help users understand the benefits of delaying the peak of the epidemic and staying below a fixed healthcare capacity. Rather than trying to map the exact dynamics of a certain location, the model shows possible trajectories under different hypothetical scenarios. The modeling framework allows for different types, intensities, and durations of interventions to be implemented, and shows how these different interventions impact the number of COVID-19 cases and fatalities through time.

Spotlight

Cancer research encompasses a broad array of research and includes a diverse range of specific research topics. Within this report, cancer research is defined as research where the published results include ‘cancer’ or ‘oncology’ within the title, abstract, or list of keywords of the publications, as indexed in the Scopus database. This includes all publication types, namely articles, reviews, conference papers, book chapters, notes, letters, short surveys, editorials, articles in press, erratum, books, conference reviews, business articles, and abstract reports. Articles represent 77% of the research, and reviews represent 14% of the publications retrieved.

Spotlight

Cancer research encompasses a broad array of research and includes a diverse range of specific research topics. Within this report, cancer research is defined as research where the published results include ‘cancer’ or ‘oncology’ within the title, abstract, or list of keywords of the publications, as indexed in the Scopus database. This includes all publication types, namely articles, reviews, conference papers, book chapters, notes, letters, short surveys, editorials, articles in press, erratum, books, conference reviews, business articles, and abstract reports. Articles represent 77% of the research, and reviews represent 14% of the publications retrieved.

Related News

HEALTH TECHNOLOGY,FUTURE OF HEALTHCARE

Sequent Service’s 3PSecure, a Privacy-Driven Healthcare Platform is Now Live

Sequent 3PSecure | June 23, 2022

Invicta Health Solutions, a premier privately-owned healthcare industry revenue cycle management provider based in the U.S. announced the launch of 3PSecure, Sequent Software's newest platform. Small-to-large healthcare systems, hospitals, and other organizations are among Invicta's clients, and the company offers enrollment and eligibility, AI/ML technologies, and claims administration solutions. "Sequent is delighted to partner with Invicta. Their executive team, led by Donny Zamora, knows how to leverage technology tools to ensure fast, flexible deployment just as we do. Invicta keeps providers, patients, and payors at the forefront of business and clinical intelligence, and the deployment of our 3PSecure platform integration will bring even more superior AI/ML analytics to the table so Invicta's healthcare clients can achieve objectives rapidly, securely, and always HIPAA and Cures Act compliant." Joan Ziegler, Chief Executive Officer, Sequent The new platform, marketed as "3PSecure, powered by Invicta," uses more than 12 years of specialized finance knowledge and is anticipated to increase Sequent's healthcare footprint as well as Invicta's capabilities in the healthcare sector. "The 3PSecure platform delivers superior business intelligence to accelerate payments to providers coupled with extraordinary clinical intelligence for high impact patient outcomes in patient treatment and prevention. More than just de-identifying EHRs, 3PSecure empowers Invicta (on behalf of its clientele) to re-identify enriched analytics at the granular patient level. Further, Sequent has provided its signature bank grade security configured to mask, redact, and tokenize any sensitive personal data wherever it is shared. The Sequent and Invicta brands are well aligned for this collaboration." Donny Zamora, Invicta's Chief Executive Officer.

Read More

HEALTH TECHNOLOGY

BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

BD | July 29, 2022

BD a leading global medical technology company, announced today it has acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. MedKeeper strategically complements BD's existing presence in the pharmacy – where the company has pioneered solutions in compounding, logistics workflow, controlled substance management and inventory optimization. MedKeeper's platform will become part of the company's existing portfolio of connected medication management capabilities. By combining MedKeeper's platform with BD's broad technology expertise, the companies will work to optimize the preparation of compounded medications – a critical need in the pharmacy today. "Preparing the right dose for patients requires a combination of factors – including personnel, training, and compliance. Pharmacy leaders require IV workflow management technology that is personalized to their needs and works within their environment. Adding MedKeeper to our portfolio will enable us to offer our customers easy to use, customizable solutions that make meaningful and incremental progress in IV workflow management." Mike Garrison, Worldwide President of Medication Management Solutions at BD Today, many pharmacies leverage a combination of both manual and technical tools for their IV workflow management system. Adding MedKeeper to BD's Medication Management Solutions portfolio will further strengthen the company's ability to deliver solutions that best meet customers' needs – now and in the future. "Demands in today's pharmacy environment, such as COVID-impacted labor shortages and changing regulatory requirements, have further exacerbated the need for customizable pharmacy software solutions to support flexible, directed workflow, inventory tracking and reporting needs in sterile and non-sterile compounding," said Garrison. "Manual, time-consuming procedures that might once have been 'good enough' now can be replaced and augmented by software that enables pharmacists to provide a higher standard of care." BD and MedKeeper will work to provide customers with flexibility and capabilities in meeting industry standards for preparing compounded medications, incorporating the latest regulatory guidance. Together, the companies are dedicated to ensuring that every customer has a workflow solution that best supports their environment and delivers efficiencies to their frontline clinicians. The transaction is expected to be immaterial to BD's fiscal 2022 financial results. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

Read More

HEALTH TECHNOLOGY

Zynx Health and LogicStream Health Power Performance Improvement Solutions

Zynx Health | July 13, 2022

Zynx Health, a pioneer and market leader in evidence- and experience-based clinical solutions, announced a strategic partnership with LogicStream Health, a leading clinical data and clinical intelligence firm. The company said the partnership is focused on delivering advanced performance improvement capabilities to health systems across the United States. The two companies have already begun rolling out this joint solution to customers. “As a pioneer in the industry and for more than a quarter of a century, Zynx Health has consistently evolved its solutions to provide best-in-class content, analytics and performance improvement tools to hospitals and health systems,” said Charles Tuchinda, MD, president of Zynx Health. “The integration of LogicStream Health’s sophisticated clinical data and intelligence software with our product portfolio is the next step in advancing the way clinical teams improve patient outcomes by directly measuring and recommending enhancements to the interventions they order.” “LogicStream, since its founding in 2013, has been focused on delivering timely, data-driven insights about areas for improvement and reduced variation in clinical process and workflows to frontline clinical teams. We are excited about joining forces with Zynx Health to help customers achieve meaningful and measurable improvements in clinical, operational and financial performance.” Patrick Yoder, PharmD, CEO of LogicStream About Zynx Health Zynx Health, a market leader in providing evidence- and experience-based clinical improvement solutions since 1996 and part of the Hearst Health network, provides healthcare professionals with vital information and processes that guide care decisions and reduce complexity across the entire patient journey in a way that leads to healthier lives for all. Named the “Best in KLAS” Category Leader for Clinical Decision Support – Care Plans and Order Sets in 2021 and 2022, Zynx is a pioneer and market leader in evidence- and experience-based clinical solutions that help health systems improve patient outcomes, financial outcomes, clinical engagement, and technology performance. With Zynx Health, healthcare organizations exceed industry demands for delivering high-quality care at lower costs under value-based reimbursement models. About LogicStream LogicStream Health, based in Minneapolis, is trusted by a community of high-performing healthcare providers and partners to generate clinical insights from clinical data. The company’s cloud-based clinical data and intelligence platform gathers, normalizes, and connects clinical data. It houses years of experience in its automated processing, advanced analytics, and machine learning. This platform serves as an underpinning for the company’s software-as-a-service (SaaS) clinical insights, data services, and life science products. As a result, customers reduce cost, improve outcomes, improve the supply chain, and accelerate research and development. Customers are generating millions of dollars in ROI from clinical intelligence using LogicStream Health’s platform.

Read More